An open label pharmcokinetic study of a topical formulation of lidocaine (SHACT) for pain relief in women receiving an Intra Uterine Device

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-005660-18

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To establish the pharmacokinetic properties of SHACT including, AUC (0-120), Cmax and tmax, when applied in cervix and uterus of women receiving an IUD.


Critère d'inclusion

  • Pain during insertion of an intra uterine device

Liens